113 related articles for article (PubMed ID: 11233797)
1. Immunomodulation by macrolide antibiotics.
Labro MT; Abdelghaffar H
J Chemother; 2001 Feb; 13(1):3-8. PubMed ID: 11233797
[TBL] [Abstract][Full Text] [Related]
2. Azithromycin: mechanisms of action and their relevance for clinical applications.
Parnham MJ; Erakovic Haber V; Giamarellos-Bourboulis EJ; Perletti G; Verleden GM; Vos R
Pharmacol Ther; 2014 Aug; 143(2):225-45. PubMed ID: 24631273
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
Amsden GW
J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
[TBL] [Abstract][Full Text] [Related]
4. Introduction: revolutionary changes in the macrolide and azalide antibiotics.
Moellering RC
Am J Med; 1991 Sep; 91(3A):1S-4S. PubMed ID: 1656735
[No Abstract] [Full Text] [Related]
5. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
Bosnar M; Kragol G; Koštrun S; Vujasinović I; Bošnjak B; Bencetić Mihaljević V; Marušić Ištuk Z; Kapić S; Hrvačić B; Brajša K; Tavčar B; Jelić D; Glojnarić I; Verbanac D; Culić O; Padovan J; Alihodžić S; Eraković Haber V; Spaventi R
J Med Chem; 2012 Jul; 55(13):6111-23. PubMed ID: 22697905
[TBL] [Abstract][Full Text] [Related]
6. Macrolide antibiotics as biological response modifiers.
Rubin BK; Tamaoki J
Curr Opin Investig Drugs; 2000 Oct; 1(2):169-72. PubMed ID: 11249569
[TBL] [Abstract][Full Text] [Related]
7. Macrolides and airway inflammation in children.
Shinkai M; Rubin BK
Paediatr Respir Rev; 2005 Sep; 6(3):227-35. PubMed ID: 16153572
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effects of macrolide antibiotics.
Culić O; Eraković V; Parnham MJ
Eur J Pharmacol; 2001 Oct; 429(1-3):209-29. PubMed ID: 11698042
[TBL] [Abstract][Full Text] [Related]
9. Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications.
Cohen-Cymberknoh M; Kerem E; Ferkol T; Elizur A
Thorax; 2013 Dec; 68(12):1157-62. PubMed ID: 23704228
[TBL] [Abstract][Full Text] [Related]
10. [Macrolides, a group of antibiotics with a broad spectrum of activity].
Hof H
Immun Infekt; 1994 Apr; 22(2):66-71. PubMed ID: 7959864
[TBL] [Abstract][Full Text] [Related]
11. Interactions of antibiotics with phagocytes in vitro.
Carlone NA; Cuffini AM; Tullio V; Cavallo G
J Chemother; 1991 Jan; 3 Suppl 1():98-104. PubMed ID: 12041799
[TBL] [Abstract][Full Text] [Related]
12. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.
López-Boado YS; Rubin BK
Curr Opin Pharmacol; 2008 Jun; 8(3):286-91. PubMed ID: 18339582
[TBL] [Abstract][Full Text] [Related]
13. Studies show new macrolide antibiotics to be superior to some older agents.
Oncology (Williston Park); 1992 Jan; 6(1):94, 96. PubMed ID: 1311184
[No Abstract] [Full Text] [Related]
14. Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells.
Saint-Criq V; Ruffin M; Rebeyrol C; Guillot L; Jacquot J; Clement A; Tabary O
Eur J Pharmacol; 2012 Jan; 674(1):1-6. PubMed ID: 22056837
[TBL] [Abstract][Full Text] [Related]
15. Erythromycin.
Brittain DC
Med Clin North Am; 1987 Nov; 71(6):1147-54. PubMed ID: 3320616
[TBL] [Abstract][Full Text] [Related]
16. Macrolide antibiotics and pulmonary inflammation.
Hoyt JC; Robbins RA
FEMS Microbiol Lett; 2001 Nov; 205(1):1-7. PubMed ID: 11728708
[TBL] [Abstract][Full Text] [Related]
17. Macrolide antibiotics.
Pallasch TJ
Dent Today; 1997 Nov; 16(11):72, 74-5, 78-9. PubMed ID: 9560736
[TBL] [Abstract][Full Text] [Related]
18. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action.
Shinkai M; Henke MO; Rubin BK
Pharmacol Ther; 2008 Mar; 117(3):393-405. PubMed ID: 18289694
[TBL] [Abstract][Full Text] [Related]
19. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion.
Aktan B; Taysi S; Gümüştekin K; Uçüncü H; Memişoğullari R; Save K; Bakan N
Pol J Pharmacol; 2003; 55(6):1105-10. PubMed ID: 14730107
[TBL] [Abstract][Full Text] [Related]
20. Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan.
Hsueh PR; Shyr JM; Wu JJ
Clin Microbiol Infect; 2006 Mar; 12(3):296-8. PubMed ID: 16451421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
